---
figid: PMC4393718__jcmm0016-2894-f2
figlink: /pmc/articles/PMC4393718/figure/fig02/
number: F2
caption: EphA/ephrinA bidirectional signalling. (A) Stimulation of ephrinA5 recruits
  and activates the Src-family kinase, FYN. Subsequently, FYN induces a change in
  the cellular architecture and adhesion of ephrinA5-expressing cells  and results
  in mitogen-activated protein kinase (MAPK) activation . (B) EphA4 activates signal
  transducers and STAT3 . EphA receptors directly activate GTPases of the Rho family
  (RHOA, RAC1 and CDC42) through the exchange factor Ephexin ,. This pathway involves
  EphA2 and PI3 kinase in endothelial cells . EphA2 inhibits Akt , and inactivates
  focal adhesion kinase (FAK) through the SHP2 phosphatase . EphA2 activates RHOA
  through FAK ,. EphA1 inhibits integrin-linked kinase (ILK). EphB/ephrinB bidirectional
  signalling. (C) Growth Factor Receptor Bound protein 4 (GRB4) contains a SH2 domain
  and can link ephrinB ligands to a signalling network that modifies cell morphology
  . EphrinB1 disrupts focal adhesions through GRB4 . The phosphatase PTP-BL is recruited
  to the ephrinB carboxy-terminal tail. PTP-BL dephosphorylates ephrinB and inactivates
  Src . PDZ-RGS3 binds constitutively to ephrinB and catalyses the hydrolysis of GTP
  to GDP in the G-Alpha subunit of heterotrimeric GPCR. It also inhibits SDF1–mediated
  cell chemotaxis through the CXCR4 . (D) EphB forward signalling activates RAC1 and
  CDC42 exchange factors ,,. EphB2 activates Ras GAP to inhibit the H-RAS and R-RAS
  ,. EphB2 regulates cell positioning via PI3K . The EphB4 receptor suppresses breast
  cancer cell tumorigenicity through an Abl-Crk pathway . EphB2 regulates cell proliferation
  through an Abl-cyclin D1 pathway .
pmcid: PMC4393718
papertitle: Eph receptors and ephrins as targets for cancer therapy.
reftext: Hong-Qing Xi, et al. J Cell Mol Med. 2012 Dec;16(12):2894-2909.
pmc_ranked_result_index: '37328'
pathway_score: 0.5472063
filename: jcmm0016-2894-f2.jpg
figtitle: EphA/ephrinA bidirectional signalling
year: '2012'
organisms: Homo sapiens
ndex: 24d4b0df-df39-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4393718__jcmm0016-2894-f2.html
  '@type': Dataset
  description: EphA/ephrinA bidirectional signalling. (A) Stimulation of ephrinA5
    recruits and activates the Src-family kinase, FYN. Subsequently, FYN induces a
    change in the cellular architecture and adhesion of ephrinA5-expressing cells  and
    results in mitogen-activated protein kinase (MAPK) activation . (B) EphA4 activates
    signal transducers and STAT3 . EphA receptors directly activate GTPases of the
    Rho family (RHOA, RAC1 and CDC42) through the exchange factor Ephexin ,. This
    pathway involves EphA2 and PI3 kinase in endothelial cells . EphA2 inhibits Akt
    , and inactivates focal adhesion kinase (FAK) through the SHP2 phosphatase . EphA2
    activates RHOA through FAK ,. EphA1 inhibits integrin-linked kinase (ILK). EphB/ephrinB
    bidirectional signalling. (C) Growth Factor Receptor Bound protein 4 (GRB4) contains
    a SH2 domain and can link ephrinB ligands to a signalling network that modifies
    cell morphology . EphrinB1 disrupts focal adhesions through GRB4 . The phosphatase
    PTP-BL is recruited to the ephrinB carboxy-terminal tail. PTP-BL dephosphorylates
    ephrinB and inactivates Src . PDZ-RGS3 binds constitutively to ephrinB and catalyses
    the hydrolysis of GTP to GDP in the G-Alpha subunit of heterotrimeric GPCR. It
    also inhibits SDF1–mediated cell chemotaxis through the CXCR4 . (D) EphB forward
    signalling activates RAC1 and CDC42 exchange factors ,,. EphB2 activates Ras GAP
    to inhibit the H-RAS and R-RAS ,. EphB2 regulates cell positioning via PI3K .
    The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk
    pathway . EphB2 regulates cell proliferation through an Abl-cyclin D1 pathway
    .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - AKT3
  - AKT2
  - PIK3CD
  - ILK
  - JAK2
  - PIK3CB
  - RASA1
  - MTTP
  - SGCA
  - AKT1
  - RAC2
  - RAC3
  - AXIN1
  - AXIN2
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PTK2
  - FYN
  - STAT3
  - PAK4
  - PAK1
  - PAK3
  - KALRN
  - MAPK14
  - MAPK1
  - MAPK3
  - MAPK8
  - CRK
  - TBL1XR1
  - ROCK2
  - MAPK13
  - PAK2
  - PIK3CG
  - PIK3R3
  - RHOG
  - RAC1
  - CDC42
  - PAK6
  - PAK5
  - NRAS
  - SRC
  - ROCK1
  - MAPK9
  - RRAS
  - MAPK10
  - MAPK12
  - KRAS
  - RHO
  - MAPK11
  - Cancer
genes:
- word: HRAS
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ILK
  symbol: ILK
  source: hgnc_symbol
  hgnc_symbol: ILK
  entrez: '3611'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: Abl
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: ADL
  symbol: ADL
  source: hgnc_prev_symbol
  hgnc_symbol: SGCA
  entrez: '6442'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AXIN
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FYN
  symbol: FYN
  source: hgnc_symbol
  hgnc_symbol: FYN
  entrez: '2534'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: KALIRIN
  symbol: Kalirin
  source: hgnc_alias_symbol
  hgnc_symbol: KALRN
  entrez: '8997'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: Crk
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
- word: DC42
  symbol: DC42
  source: hgnc_alias_symbol
  hgnc_symbol: TBL1XR1
  entrez: '79718'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: CDC42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RRAS
  symbol: RRAS
  source: hgnc_symbol
  hgnc_symbol: RRAS
  entrez: '6237'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RHO
  symbol: RHO
  source: hgnc_symbol
  hgnc_symbol: RHO
  entrez: '6010'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4393718__F2
redirect_from: /figures/PMC4393718__F2
figtype: Figure
---
